Claritev Corporation (CTEV)
Claritev Corporation (CTEV) provides data analytics and technology-enabled solutions to the healthcare industry. They focus on cost management, payment integrity, and revenue integrity.
Company Overview
Claritev Corporation (CTEV) offers data-driven solutions for healthcare cost management and revenue integrity, leveraging advanced analytics and technology to optimize benefit plan design and reduce costs for insurers and healthcare providers, positioning them as a key player in healthcare efficiency.
Investment Thesis
Claritev Corporation presents a compelling investment opportunity within the healthcare information services sector. The company's focus on data analytics and technology-enabled cost management solutions positions it to capitalize on the growing need for efficiency and cost reduction in the healthcare industry. Despite a current negative P/E ratio of -1.25 and a profit margin of -35.9%, the company's high gross margin of 74.7% indicates strong potential for profitability with improved cost controls. Key value drivers include the increasing adoption of data analytics in healthcare, the rising demand for payment and revenue integrity solutions, and the company's ability to expand its customer base and service offerings. Upcoming catalysts include potential partnerships with major healthcare providers and the launch of new data analytics products. Given the market cap of $0.43B, CTEV offers substantial upside potential if it can execute its growth strategy and achieve profitability.
Key Highlights
- Gross Margin of 74.7% demonstrates strong pricing power and efficient service delivery.
- Market Cap of $0.43B indicates potential for growth and value appreciation.
- Beta of 0.53 suggests lower volatility compared to the overall market.
- Serves a diverse client base including national and regional insurance companies, Blue Cross and Blue Shield plans, and TPAs.
- Focus on data analytics and technology-enabled solutions aligns with the growing demand for cost management in healthcare.
Competitors
Strengths
- Comprehensive suite of data analytics and technology-enabled solutions.
- Strong expertise in healthcare cost management and revenue integrity.
- Established relationships with a diverse client base.
- High gross margin of 74.7%.
Weaknesses
- Negative P/E ratio of -1.25.
- Negative profit margin of -35.9%.
- Reliance on the US healthcare market.
- Limited brand recognition compared to larger competitors.
Catalysts
- Upcoming: Potential partnerships with major healthcare providers to expand customer base.
- Ongoing: Increasing adoption of data analytics in the healthcare industry.
- Ongoing: Rising demand for payment and revenue integrity solutions.
- Upcoming: Launch of new data analytics products and services.
Risks
- Potential: Increasing competition from other healthcare IT companies.
- Potential: Changes in healthcare regulations and reimbursement policies.
- Potential: Economic downturn affecting healthcare spending.
- Ongoing: Cybersecurity threats and data breaches.
- Ongoing: Inability to achieve profitability and positive cash flow.
Growth Opportunities
- Expansion of Data Analytics Services: CTEV can further expand its data analytics services by developing new solutions that address emerging needs in the healthcare industry. The market for healthcare analytics is projected to reach $75 billion by 2028, driven by the increasing adoption of data-driven decision-making in healthcare. By investing in research and development and forming strategic partnerships, CTEV can capture a larger share of this growing market. Timeline: Ongoing.
- Strategic Partnerships with Healthcare Providers: Forming strategic partnerships with major healthcare providers can provide CTEV with access to a larger customer base and valuable data insights. These partnerships can also enable CTEV to develop customized solutions that address the specific needs of healthcare providers. The market for healthcare partnerships is estimated to be worth $20 billion annually. Timeline: Upcoming.
- Geographic Expansion: CTEV can expand its geographic reach by targeting new markets in the United States and internationally. The global healthcare IT market is projected to reach $440 billion by 2026, driven by the increasing adoption of healthcare IT solutions in developing countries. By establishing a presence in new markets, CTEV can diversify its revenue streams and reduce its reliance on the US market. Timeline: Ongoing.
- Development of New Technology Solutions: Investing in the development of new technology solutions, such as artificial intelligence and machine learning, can enable CTEV to offer more advanced and efficient services. The market for AI in healthcare is projected to reach $34 billion by 2027, driven by the increasing adoption of AI-powered solutions in healthcare. By developing new technology solutions, CTEV can differentiate itself from its competitors and attract new customers. Timeline: Ongoing.
- Acquisition of Complementary Businesses: CTEV can acquire complementary businesses to expand its service offerings and customer base. The market for healthcare acquisitions is estimated to be worth $100 billion annually. By acquiring companies with complementary capabilities, CTEV can create synergies and enhance its competitive position. Timeline: Potential.
Opportunities
- Expansion of data analytics services.
- Strategic partnerships with healthcare providers.
- Geographic expansion into new markets.
- Development of new technology solutions, such as AI and machine learning.
Threats
- Increasing competition from other healthcare IT companies.
- Changes in healthcare regulations and reimbursement policies.
- Economic downturn affecting healthcare spending.
- Cybersecurity threats and data breaches.
Competitive Advantages
- Proprietary data analytics algorithms and technology.
- Established relationships with a diverse client base.
- Expertise in healthcare cost management and revenue integrity.
- Comprehensive suite of services covering the entire healthcare payment cycle.
About
Founded in 1980 and headquartered in New York City, Claritev Corporation (CTEV) is a leading provider of data analytics and technology-enabled solutions for the healthcare industry. Originally known as MultiPlan Corporation, the company rebranded as Claritev Corporation in February 2025, signaling a renewed focus on innovation and technology. CTEV's core business revolves around offering a suite of services designed to help healthcare organizations manage costs, ensure payment accuracy, and optimize revenue. These services include analytics-based solutions that leverage data-driven algorithms to detect claims overcharges and negotiate reimbursements, as well as network-based services that provide contracted discounts with healthcare providers. CTEV's payment and revenue integrity services focus on identifying and removing improper charges, while also working to restore underpaid premium dollars. The company's data and decision science services offer descriptive, predictive, and prescriptive analytics to improve benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care. CTEV serves a diverse range of clients, including national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. CTEV is committed to driving efficiency and value in the healthcare system through its innovative technology and data-driven insights.
What They Do
- Provides data analytics services to reduce medical costs.
- Offers technology-enabled cost management solutions.
- Delivers payment and revenue integrity services.
- Detects claims over-charges and negotiates reimbursements.
- Provides contracted discounts with healthcare providers.
- Offers outsourced network development and management services.
- Applies data science to improve clinical outcomes and reduce the total cost of care.
Business Model
- Generates revenue through fees for data analytics services.
- Earns revenue from payment and revenue integrity solutions.
- Receives fees for network-based services and contracted discounts.
- Provides data and decision science services on a subscription or project basis.
FAQ
What does Claritev Corporation do?
Claritev Corporation provides data analytics and technology-enabled solutions to the healthcare industry, focusing on cost management, payment integrity, and revenue integrity. The company offers a suite of services, including analytics-based solutions that detect claims overcharges, network-based services that provide contracted discounts, and data and decision science services that improve benefit plan design and clinical outcomes. CTEV serves a diverse range of clients, including insurance companies, health plans, and TPAs, helping them to optimize their operations and reduce costs through data-driven insights.
Is CTEV stock a good buy?
CTEV stock presents a mixed investment profile. While the company's high gross margin of 74.7% and focus on a growing market segment are positive indicators, its negative P/E ratio of -1.25 and profit margin of -35.9% raise concerns about profitability. Investors should consider the company's growth potential, driven by increasing demand for healthcare data analytics, against the risks of competition and regulatory changes. A turnaround strategy focused on cost control and revenue growth could make CTEV a compelling investment, but it requires careful monitoring of financial performance and market trends.
What are the main risks for CTEV?
The main risks for CTEV include increasing competition from other healthcare IT companies, changes in healthcare regulations and reimbursement policies, and the potential for an economic downturn affecting healthcare spending. Cybersecurity threats and data breaches also pose a significant risk, given the sensitive nature of healthcare data. Additionally, the company's current lack of profitability and negative cash flow raise concerns about its long-term financial sustainability. Effective risk management and a clear path to profitability are crucial for CTEV to overcome these challenges.
Industry Context
Claritev Corporation operates within the healthcare information services industry, a sector experiencing significant growth due to the increasing complexity of healthcare finance and the need for cost containment. The industry is characterized by a growing demand for data analytics, revenue cycle management, and payment integrity solutions. CTEV competes with other healthcare IT companies, including Axogen (AXGN), Dentsply Sirona (DNTH), Envision Healthcare (EVH), GoodRx Holdings (GDRX), and iArtisan Healthcare Acquisition Corp (IART). These companies offer various solutions, but CTEV differentiates itself through its comprehensive suite of data analytics and technology-enabled services. The market is expected to continue growing as healthcare providers and payers seek to improve efficiency and reduce costs.
Key Customers
- National and regional insurance companies
- Blue Cross and Blue Shield plans
- Provider-sponsored and independent health plans
- Third-party administrators (TPAs)
- Self-insured health plans
Financials
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $246M | -$70M | $-4.23 |
| Q2 2025 | $242M | -$63M | $-3.81 |
| Q1 2025 | $231M | -$71M | $-4.38 |
| Q4 2024 | $232M | -$138M | $-8.54 |
Source: Company filings
Chart & Info
Price Chart
Claritev Corporation (CTEV) stock price: $29.53 (-4.36, -12.87%)
Why Bull
- •Recent insider buying suggests confidence in CTEV's future, indicating that leadership sees potential growth.
- •Community sentiment has turned positive, with discussions highlighting CTEV's innovative projects and their potential impact.
- •Analysts are noting improved operational efficiency, which could enhance profitability in the coming quarters.
- •Recent partnerships have been well-received, showcasing CTEV's ability to adapt and expand its market presence.
Why Bear
- •Concerns over market competition have been voiced, with some community members questioning CTEV's ability to maintain its edge.
- •Recent earnings reports revealed challenges that have led to skepticism regarding future performance.
- •Social sentiment includes caution about regulatory hurdles that could impact CTEV's growth trajectory.
- •Some investors are expressing doubts about the sustainability of CTEV's recent momentum, fearing it may be short-lived.
Latest News
-
12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga · Nov 13, 2025
-
Earnings Scheduled For November 7, 2025
benzinga · Nov 7, 2025
-
Earnings Scheduled For August 6, 2025
benzinga · Aug 6, 2025
-
Earnings Scheduled For May 8, 2025
benzinga · May 8, 2025
Technical Analysis
Rationale
AI-generated technical analysis for CTEV including trend direction, momentum, and pattern recognition.
What to Watch
Key support and resistance levels, volume signals, and upcoming events.
Risk Management
Position sizing, stop-loss levels, and risk-reward assessment.
Community
Discussion
Share your analysis and discuss Claritev Corporation (CTEV) with other investors. Log in to post.
Sentiment
Community sentiment and discussion activity for CTEV.
Make a Prediction
Set your price target for Claritev Corporation (CTEV), choose a timeframe, and track your prediction accuracy.
Current price: $29.53
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CTEV.
Price Targets
Median: $33.00 (+11.8% from current price)
Insider Flow (30d)
MoonshotScore
Score Factors
- Revenue Growth 2/100
- Gross Margin 10/100
- Operating Leverage 4/100
- Cash Runway 5/100
- R&D Intensity 5/100
- Insider Activity 6/100
- Short Interest 10/100
- Price Momentum 0/100
- News Sentiment 5/100
What does this score mean?
The MoonshotScore rates CTEV's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Frequently Asked Questions
What does Claritev Corporation do?
Claritev Corporation provides data analytics and technology-enabled solutions to the healthcare industry, focusing on cost management, payment integrity, and revenue integrity. The company offers a suite of services, including analytics-based solutions that detect claims overcharges, network-based services that provide contracted discounts, and data and decision science services that improve benefit plan design and clinical outcomes. CTEV serves a diverse range of clients, including insurance companies, health plans, and TPAs, helping them to optimize their operations and reduce costs through data-driven insights.
Is CTEV stock a good buy?
CTEV stock presents a mixed investment profile. While the company's high gross margin of 74.7% and focus on a growing market segment are positive indicators, its negative P/E ratio of -1.25 and profit margin of -35.9% raise concerns about profitability. Investors should consider the company's growth potential, driven by increasing demand for healthcare data analytics, against the risks of competition and regulatory changes. A turnaround strategy focused on cost control and revenue growth could make CTEV a compelling investment, but it requires careful monitoring of financial performance and market trends.
What are the main risks for CTEV?
The main risks for CTEV include increasing competition from other healthcare IT companies, changes in healthcare regulations and reimbursement policies, and the potential for an economic downturn affecting healthcare spending. Cybersecurity threats and data breaches also pose a significant risk, given the sensitive nature of healthcare data. Additionally, the company's current lack of profitability and negative cash flow raise concerns about its long-term financial sustainability. Effective risk management and a clear path to profitability are crucial for CTEV to overcome these challenges.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Data provided for informational purposes only.